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adiposity. Ex vivo adipokine secretion from adipose tissue 
explants remained largely unchanged after feeding.
Conclusions Increased systemic measures of postpran-
dial metabolism with greater adiposity do not translate into 
increased inflammatory responses within adipose tissue. 
Instead, postprandial adipose tissue changes may represent 
a normal response to feeding or a (relatively) normalized 
response with increased adiposity due to either similar net 
exposure (i.e. per g of adipose) or reduced adipose tissue 
responsiveness.
Keywords Adipose tissue · Metabolism · Inflammation · 
Postprandial · Human
Introduction
Adipose tissue expansion is accompanied by a more pro-
inflammatory gene expression profile which, together with 
increased secretion of inflammatory cytokines, may con-
tribute to systemic low-grade inflammation and insulin 
resistance [1]. The vast majority of what we know about 
adipose tissue is restricted to observations derived after an 
overnight fast. However, adipose tissue is a dynamic player 
in overall metabolic regulation, and it cannot be assumed 
that fasted measurements will adequately reflect the overall 
role and function of adipose tissue, particularly since the 
majority of the waking day is spent in a fed (i.e. postpran-
dial) state.
Obesity typically increases postprandial glucose, insu-
lin and triglyceride responses in blood [2, 3], and it is rea-
sonable to anticipate that this could alter the adipose tis-
sue responses to a meal. Surprisingly few studies to date 
have investigated the presence of postprandial inflamma-
tion within adipose tissue in humans, typically comparing 
Abstract 
Purpose Most of what we know about adipose tissue is 
restricted to observations derived after an overnight fast. 
However, humans spend the majority of waking hours in a 
postprandial (fed) state, and it is unclear whether increas-
ing adiposity impacts adipose tissue responses to feed-
ing. The aim of this research was to investigate postpran-
dial responses in adipose tissue across varying degrees of 
adiposity.
Methods Thirty males aged 35–55 years with waist cir-
cumference 81–118 cm were divided equally into groups 
categorized as either lean, overweight or obese. Participants 
consumed a meal and insulinaemic, glycaemic and lipidae-
mic responses were monitored over 6 h. Subcutaneous adi-
pose tissue samples were obtained at baseline and after 6 h 
to examine changes in gene expression and adipose tissue 
secretion of various adipokines.
Results Following consumption of the meal, insulin and 
glucose responses were higher with increased adipos-
ity (total AUC effects of group; p = 0.058 and p = 0.027, 
respectively). At 6 h, significant time effects reflected 
increases in IL-6 (F = 14.7, p = 0.001) and MCP-1 
(F = 10.7, p = 0.003) and reduction in IRS2 adipose tissue 
gene expression (F = 24.6, p < 0.001), all independent of 
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postprandial responses to differing qualities/quantities of 
lipids in people with metabolic syndrome [4] or compar-
ing responses in (non-obese) relatives of people with type 
2 diabetes versus controls [5]. In both these studies, signifi-
cant increases in adipose tissue gene expression of a num-
ber of inflammatory genes including MCP-1, TNF-α, IL-1β 
and IL-6 were detected, suggesting that there may indeed 
be postprandial inflammatory responses in adipose tissue 
[4, 5]. Remarkably, there has been no attempt to compare 
postprandial responses within adipose tissue between lean 
and obese individuals. Thus, it is unclear whether these 
changes in inflammatory markers in adipose tissue rep-
resent a ‘normal’ phenomenon or something that is influ-
enced by increasing adiposity, as is the case with other 
more systemic changes (e.g. insulinaemia). This is central 
to our understanding of obesity-related inflammation and 
chronic disease.
The aim of this research was to investigate whether the 
greater postprandial metabolic response (i.e. hyperinsu-
linaemia) observed with increased adiposity leads to an 




Thirty men aged between 35 and 55 years were recruited 
by local advertisement and following preliminary anthro-
pometric assessment and were classified according to waist 
circumference as lean ≤94 cm, overweight 94–102 cm 
and obese ≥102 cm [6]. Recruitment was on a first-come 
first-served basis and took place between September 2011 
and April 2012 until there were 10 participants in each 
waist circumference category. Participants attended one 
main trial in the Physiology Laboratories at the University 
of Bath, in which blood and adipose tissue samples were 
obtained before and 6 h after consumption of a mixed 
meal with further blood samples taken at regular intervals 
throughout. Primary outcome measures included exami-
nation of changes in adipose tissue gene expression and 
secretion of selected cytokines from adipose explants after 
the meal according to levels of adiposity (and postprandial 
metabolic responses in blood). This trial forms part of a 
larger investigation in which immune cells present in adi-
pose tissue were characterized and their relationships with 
baseline adipose tissue inflammation examined, as has been 
previously reported [7]. All procedures followed were in 
accordance with the protocol reviewed and approved by the 
National Health Service South West (Southmead) Research 
Ethics Committee (11/SW/0193) and have therefore been 
performed in accordance with the ethical standards laid 
down in the 1964 Declaration of Helsinki and its later 
amendments. This trial is registered at ClinicalTrials.gov 
(ID: NCT02416843), and all participants gave their writ-
ten informed consent prior to their inclusion in the study. 
Individuals were excluded from participation if they had a 
history of diabetes, cardiovascular disease or dyslipidae-
mia, were taking any medications known to interfere with 
immune function or lipid/carbohydrate metabolism, if they 
smoked or had not been weight stable for >3 months (i.e. 
weight change >3 %; [8]). In addition, participants were 
excluded if they reported food intolerances/allergies to any 
component of the meal (e.g. dairy or wheat) and habitu-
ally performed more than 6 h of vigorous-intensity physi-
cal activity or 10 h of moderate-intensity physical activity 
per week, assessed via a self-report questionnaire (as these 
individuals would be unlikely to fit the meal standardiza-
tion procedure). Participant characteristics within the cat-
egories lean, overweight and obese based on measurements 
of waist circumference are given in Table 1.
Sample size determination
The sample size for this study was determined using a 
clinically relevant difference in serum insulin response to a 
meal between lean [AUC 93 µU/mL (±29 SD)] and obese 
[AUC 169 µU/mL (±51 SD)] individuals with an effect 
size of 1.8 (G*Power 3.1.5, Germany) [9]. Thus, with 95 % 
power and 5 % alpha, 18 participants (nine lean and nine 
obese) would be required to detect a statistically significant 
difference in serum insulin AUC between groups.
Preliminary measurements
Participant waist circumference, body mass and height 
were measured and body mass index calculated [BMI; 
mass (kg)/height2 (m2)]. Participants were fitted with a 
combined heart rate and accelerometry monitor (Actiheart) 
for a period of 9 consecutive days to determine habitual 
physical activity level (PAL; total energy expenditure/basal 
metabolic rate [10]). Participants were asked to maintain 
their normal lifestyle habits/routines during this period 
with the first 2 days of activity monitoring being excluded 
from analysis to account for potential reactivity [11].
Main trial
Participants were asked to refrain from performing any 
strenuous physical activity for 48 h and consuming alcohol/
caffeine for 24 h prior to testing. Trial days were scheduled 
so participants had been free from any self-reported illness 
for a minimum of 2 weeks in order to reduce immune sys-
tem disturbance. Participants arrived in the laboratory in 
the morning after an overnight fast (minimum 10 h) and 
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after consuming 1 pint of water upon waking. Body mass 
(post-void) was determined using a digital balance (Tanita 
Corp., Japan) with participants wearing lightweight shorts. 
Dual-energy X-ray absorptiometry (DEXA; Discovery, 
Hologic, Bedford, UK) was used to estimate lean and fat 
mass. Central adipose tissue (abdominal subcutaneous and 
visceral adipose tissue) was estimated from a central region 
between L1 and L4 which has previously been shown to be 
comparable to estimates of central adipose tissue measured 
by computerized tomography (CT) [12] and correlates with 
measures of metabolic health [13]. Fat mass index (FMI) 
was calculated using the equation FMI = total fat mass 
(kg)/height2 (m2) and interpreted using ranges that match 
the WHO BMI classifications [14]. Indirect calorimetry 
was used to estimate resting metabolic rate (RMR) after 
participants had rested supine in bed for 10 min [15]. This 
value was used to adjust estimates of total energy expendi-
ture and PAL and to calculate the energy requirements for 
the test meal given to participants.
Meal composition and energy requirements
Participants were given a breakfast meal relative to their 
resting metabolic rate comprising brioche, strawberry jam 
(both Sainsbury’s, UK), margarine (Stork, Unilever), milk-
shake (fresh chocolate milk and whipping cream; both 
Sainsbury’s, UK, with added icing sugar; Silver Spoon) and 
a cup of decaffeinated tea (PG tips, Unilever) with semi-
skimmed milk (Sainsbury’s, UK). The total energy content 
of the meal represented approximately 65 % RMR and 
comprised 39 % calories from carbohydrate, 54 % calories 
from fats and 7 % calories from protein. The exact compo-
sition of the meal was designed to ensure that an average 
80 kg man with an RMR of 1791 kcal/day (estimated from 
Schofield equation; [16] received 1.5 g/kg carbohydrate 
[17]. A worked example showing exact proportions of each 
meal item is available in the supplementary information 
online. During the trial, participants were free to consume 
water ad libitum but consumed no further food until the end 
of the trial.
The standardized mixed meal with a high carbohydrate 
and fat content was intended to produce a more ‘physiolog-
ical’ response compared with glucose or fat only challenges 
[18]. The meal was given relative to each individual’s rest-
ing metabolic rate to standardize energy intake for inter-
individual differences in body mass/composition and thus 
resting energy requirements.
Blood and adipose sampling before and after meal 
consumption
Venous blood samples were taken from an antecubital fore-
arm vein via a cannula and dispensed into separate tubes 
containing either K3EDTA or serum separation beads 
(Sarstedt Ltd., Leicester, UK) for plasma and serum sepa-
ration, respectively. Samples for plasma separation were 
immediately centrifuged (3465 g for 10 min at 4 °C), 
whereas serum tubes were left to clot for 45 min prior to 
centrifugation. Subcutaneous adipose tissue samples (~1 g) 
were obtained under local anaesthetic (1 % lidocaine) 
Table 1  Descriptive statistics of participants classified according to waist circumference
Mean (SEM) values shown and statistical differences between the three groups were assessed by one-way ANOVA, p values shown. Abbrevia-
tions used: L1-L4 = central fat estimated between Lumbar regions 1–4 using DEXA; PAL = physical activity level which is the product of total 
energy expenditure ÷ basal metabolic rate (Ilean n = 9); NEFA non-esterified fatty acids
Classification based on waist circumference Lean n = 10 Overweight n = 10 Obese n = 10 One-way ANOVA
p
Age (years) 44 (2) 48 (2) 45 (2) 0.218
Height (m) 1.78 (0.02) 1.77 (0.02) 1.81 (0.03) 0.469
Body mass (kg) 74.8 (1.6) 83.7 (1.8) 100.2 (3.3) <0.001
Body mass index (kg/m2) 23.6 (0.6) 26.7 (0.4) 30.7 (0.9) <0.001
Waist circumference (cm) 87.0 (1.4) 97.7 (0.8) 109.4 (1.8) <0.001
Fat mass index (kg/m2) 4.5 (0.3) 6.9 (0.2) 9.5 (0.6) <0.001
L1-L4 fat (%) 19 (1) 30 (1) 37 (2) <0.001
Resting metabolic rate (kcal/day) 1644 (65) 1722 (55) 1882 (74) 0.045
PALI 1.94 (0.10) 1.66 (0.06) 1.67 (0.10) 0.066
Energy consumed in test meal (kcal) 1063 (42) 1113 (36) 1217 (48) 0.045
Fasting glucose (mmol/L) 4.4 (0.3) 4.8 (0.3) 5.3 (0.2) 0.043
Fasting insulin (pmol/L) 27.3 (4.8) 39.6 (7.0) 59.5 (10.1) 0.020
Fasting triglycerides (mmol/L) 0.9 (0.1) 1.3 (0.2) 1.0 (0.1) 0.123
Fasting NEFA (mmol/L) 0.33 (0.04) 0.48 (0.13) 0.43 (0.05) 0.469
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approximately 5 cm lateral to the umbilicus using a ‘needle 
aspiration’ technique [19].
After baseline blood and adipose tissue sampling, the 
meal was consumed within 15 min. Further blood samples 
were taken from the cannula at 15, 30, 60 and 90 min and 
then at every hour until 6 h after consumption of the meal. 
A second adipose sample was also taken at 6 h on the con-
tralateral side of the umbilicus to the sample collected at 
baseline to allow time for measureable changes to occur 
following peaks in both blood glucose and triglycerides 
following consumption of the meal. At both sampling time 
points, approximately 200 mg adipose tissue was homog-
enized in Trizol (Invitrogen, Paisley, UK) and processed 
for gene expression analysis and small portions cultured 
for analysis of adipokine secretion ex vivo over 3 h [7]. For 
tissue culture, adipose tissue was minced into ~5–10 mg 
explants and incubated with endothelial cell basal media 
(Promocell, Germany) supplemented with 0.1 % fatty 
acid-free bovine serum albumin, 100 U/mL penicillin and 
0.1 mg/mL streptomycin (Sigma-Aldrich, Gillingham, 
UK). Tissue was incubated at a final concentration of 
approximately 100 mg tissue per 1 mL in duplicate for 3 h 
at 37 °C, 5 % CO2 and 95 ± 5 % relative humidity (MCO-
18A1C CO2 incubator; Sanyo, Japan). Adipokine secretion 
from adipose tissue explants was corrected for the mass 
of tissue cultured and adjusted to central fat mass (L1-L4 
from DEXA) as described previously [7].
RT‑PCR
Total RNA was extracted from whole adipose tissue using 
the RNeasy mini kit (Qiagen, Crawley, UK). Samples were 
quantified (Qubit 2.0 fluorimeter, Life Technologies, Paisley, 
UK) and 2 μg reverse transcribed to cDNA using a high-
capacity reverse transcription kit (Applied Biosystems, War-
rington, UK). Real-time PCR was performed using a Ste-
pOne™ (Applied Biosystems) using pre-designed primers 
and probes obtained from Applied Biosystems for measure-
ment of glucose transporter type 4 (GLUT4; Hs00168966_
m1), insulin receptor substrate 2 (IRS2; Hs00275843_s1), 
hormone-sensitive lipase (HSL; Hs00193510_m1), leptin 
(Hs00174877_m1), adiponectin (Hs00605917_m1), mono-
cyte chemoattractant protein 1 (MCP-1; Hs00234140_
m1), interferon gamma-induced protein 10 (IP-10; 
Hs01124251_g1), interleukin 6 (IL-6; Hs00985639_m1), 
interleukin 8 (IL-8; Hs99999034_m1), interleukin 10 (IL-10; 
Hs00961619_m1), interleukin 1 receptor antagonist (IL-1Ra; 
Hs00893626_m1), tumour necrosis factor alpha (TNF-α; 
Hs99999043_m1), interleukin 1 beta (IL-1β; Hs01555410_
m1) and interleukin 18 (IL-18; Hs00155517_m1) expres-
sion. Adipose tissue expression of GCSF, MIP-1b and IFN-ɣ 
was also measured, but data are not shown because they were 
only detectable in 4–8 individuals. Peptidylprolyl isomerase 
A (PPIA/cyclophilin A) was used as an endogenous con-
trol [20]. Results were analysed using the comparative Ct 
method and expression normalized to an internal calibra-
tor specific to each gene using the formula 2−CT (where 
∆∆CT is [(CT gene of interest − CT PPIA) − lowest ∆CT 
for gene of interest], and statistical analysis was performed 
on LN-transformed values [21].
Biochemical analysis
Serum insulin was measured by ELISA (Mercodia, Upp-
sala, Sweden), and plasma glucose, serum total cholesterol, 
HDL cholesterol, ALT and triglycerides were measured 
using commercially available assay kits and analyser (Day-
tona Rx, Randox, Crumlin, UK). Adipose tissue secretion 
of IL-6, IL-8, IL-10, IL-1Ra, IP-10, GCSF, MCP-1, MIP-
1b and TNF-α was measured using Luminex (Bio-Rad, 
Hercules, CA, USA).
Statistical analysis
All data are presented as mean ± standard error of the mean 
(SEM). Total area under the curve (AUC) for insulin, glu-
cose, triglycerides and NEFA was calculated using the tra-
pezium rule and homoeostasis model assessment for insulin 
resistance (HOMA-IR) calculated using the formula fasting 
glucose (mmol/L) × fasting insulin (mU/L)/22.5 [22]. Adi-
pose tissue responses to the meal were compared between the 
three groups using mixed-model ANOVA (adiposity × time) 
irrespective of minor deviations from a normal distribu-
tion within the normal physiological range [23]. Green-
house–Geisser corrections were applied to intra-individual 
contrasts where ε < 0.75; however, for less severe aspheric-
ity the Huynh–Feldt correction was selected [24]. Where 
mixed-model ANOVA identified significant interactions 
effects, multiple t tests were applied to identify the location 
of variance both within each group relative to baseline and 
between groups at level time points, with p values subject 
to a Holm–Bonferroni correction [24]. Statistical analysis 
was performed using SPSS version 20 (IBM, Armonk, NY, 
USA) using an alpha level of p ≤ 0.05. The symbols used 
to identify significant differences are as follows: * denotes a 
main effect of time, † denotes a main effect of adiposity and 
# denotes any adiposity × time interaction effects.
Results
Fasting and postprandial blood measures of glucose 
and lipid metabolism
Temporal insulin and glucose responses following the meal 
and their respective AUCs were elevated with increasing 
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magnitude in proportion to increased adiposity (Fig. 1a, 
b). No such differences were apparent, however, for the 
temporal responses or AUCs for NEFA or triglycerides 
(Fig. 1c, d).
Changes in adipose tissue gene expression at 6 h 
following the meal
At 6 h after the meal, significant time effects reflected an 
up-regulation of IL-6 (F = 14.7, p = 0.001) and MCP-1 
(F = 10.7, p = 0.003) and down-regulation of IRS2 
(F = 24.6, p < 0.001) gene expression across all groups 
relative to baseline (Fig. 2). Greater expression of IL-18 
(F = 8.3, p = 0.002), IP-10 (F = 4.1, p = 0.029), IL-1Ra 
(F = 6.1, p = 0.006) and MCP-1 (F = 8.8, p = 0.001) and 
lower expression of GLUT4 (F = 9.9, p = 0.001), IRS2 
(F = 5.2, p = 0.012) and HSL (F = 4.8, p = 0.016) with 
increased adiposity were maintained over the 6-h post-
prandial period monitored in subcutaneous adipose tissue 
(Fig. 2). No differences in magnitude or direction of these 
responses were identified between groups (i.e. no adipos-
ity × time interactions were apparent).
Adipose tissue secretion before and after the meal
Baseline secretion of adipokines from adipose tis-
sue together with changes following the meal is given in 
Table 2. Despite changes in gene expression of IL-6 and 
MCP-1 at 6 h following the meal, no significant changes 
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(b)† p = 0.056
Fig. 1  Blood glucose, insulin, triglyceride and NEFA responses over 
the 6 h following consumption of the meal for lean, overweight and 
obese individuals classified based on waist circumference. Tempo-
ral responses and total area under the curves (T-AUC) for a plasma 
glucose, b serum insulin, c serum triglycerides and d serum NEFA 
(n = 30). Mixed-model ANOVAs were performed with post hoc t 
tests applied to identify which specific time points were different 
from baseline; * denotes effect of time (p < 0.05) compared with 
t = 0; † denotes main effect of adiposity (p < 0.05). Total AUC com-
pared using one-way ANOVA and p values shown. L lean, Ov over-
weight, Ob obese
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were identified for IP-10 (F = 4.3, p = 0.029) and IL-10 
(F = 5.2, p = 0.017); however, post hoc t tests only indi-
cated that IL-10 secretion from the obese adipose tissue 
was reduced to a level similar to the overweight group at 
6 h (p < 0.05). Effects of adiposity on secretion were main-
tained across both time points for IL-6, MCP-1, GCSF, 
IP-10, MIP-1b and IL-10. Due to the limited size of some 
adipose tissue samples obtained, there was only sufficient 
material to culture tissue for six lean and five overweight 
individuals.
Discussion
The present study investigated systemic and adipose tissue 
metabolic and immune responses to a mixed meal in men 
with varying levels of adiposity. Although the magnitude of 
glucose and insulin responses to the meal were proportion-
ate to increased levels of adiposity, up-regulation of IL-6 
and MCP-1 and down-regulation of IRS2 gene expression 
in subcutaneous adipose tissue occurred to a similar extent 
Fig. 2  Relative gene expression 
in whole adipose tissue samples 
before and 6 h after consump-
tion of a meal. Data presented 
as mean (SEM) with partici-
pants classified equally based 
on waist circumference. Expres-
sion is relative to a housekeep-
ing gene (cyclophilin A/PPIA) 
and an internal calibrator spe-
cific to each gene and statistics 
performed on LN-transformed 
values. Groups were compared 
by mixed-model ANOVA; † 
denotes main effect of adipos-
ity; * denotes significant main 
effect of time (p < 0.05) across 
the three groups. There were 
no significant adiposity × time 
interaction effects. Note 
IL-1β n = 27 after 2 outli-
ers from IL-1β data excluded 
as >Q3 + (1.5 × IQR). Any 
samples above the threshold 
value (Ct > 35) were deemed 
undetectable and excluded 
from analysis. For all genes, 
n = 30 except where samples 
were outside the detectable 
limit Ct > 35 and were excluded 
from analysis; IL-10; n = 14 
(lean n = 2, overweight n = 6, 
obese n = 6), IL-6; n = 28 
(lean n = 8, overweight n = 10, 
obese n = 10), IL-8; n = 26 
(lean n = 6, overweight n = 10, 
































































































































 †  
 †  †*   †  
 †  
 †  †*  
 *  



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































382 Eur J Nutr (2017) 56:375–385
1 3
in lean through to obese men 6 h following ingestion of the 
meal.
Postprandial responses in adipose tissue with adiposity 
and insulin resistance
Within adipose tissue, gene expression of the typically pro-
inflammatory cytokines IL-6 and MCP-1 were increased 
6 h following consumption of the meal, which supports 
previous findings from people with metabolic syndrome [4] 
and non-obese relatives of people with type 2 diabetes [5]. 
The magnitude of changes in IL-6, MCP-1 and IRS2 gene 
expression observed in the present study was equal across 
all groups from lean to class I obese despite poorer glucose 
control/poorer insulin sensitivity with increasing levels of 
adiposity and despite participants with increased adiposity 
receiving a larger meal (since the meal was given relative 
to RMR). This indicates that these responses may be part 
of a ‘normal’ postprandial response within adipose tissue, 
at least within 6 h following a meal. A possible explana-
tion for the similar responses is that relative insulin resist-
ance in obese adipose tissue (suggested by the chronic 
down-regulation of GLUT4, HSL and IRS2) may counter-
act the increased insulin response to the meal and result in 
the same overall effect as in lean ‘insulin-sensitive’ tissue. 
Furthermore, given the increased relative mass of adipose 
tissue in obese individuals compared with lean, exposure 
of each gram of adipose tissue to insulin and glucose may 
actually be comparable.
Potential stimuli of gene expression changes in adipose 
tissue
The meal used in this study was relatively high in both car-
bohydrates and fats. However, it cannot be determined from 
this study whether either of these or another factor related 
to the ingestion of either of these meal components (e.g. 
insulin) is the main stimulus for the increased gene expres-
sion of inflammatory cytokines in adipose tissue. Certainly, 
there is good evidence that insulin infusion alone increases 
IL-6 and TNF-α expression in subcutaneous adipose tissue 
from lean men [25, 26] and expression of IL-6, MCP-1 and 
IL-1β in rodents [27]. The effect of 3 h of hyperglycaemia 
alone (in the absence of increased insulin) on adipose tissue 
gene expression has also been examined [28], and although 
IL-6 and MCP-1 were not reported to be affected [28], 
this does not exclude glucose as a stimulus for the gene 
expression changes observed since different sampling time 
points were used. Assuming that the meal was indeed the 
key stimulus for changes in adipose tissue gene expression, 
another component to consider is triglycerides which, like 
the changes in adipose tissue gene expression, showed no 
differences in magnitudes of response with increased levels 
of adiposity. High-fat meal challenges have been shown 
to induce inflammation in adipose tissue [4, 29], and the 
type of fat (i.e. saturated or unsaturated) is not thought 
to be important in determining the extent of postprandial 
inflammation in adipose tissue [4]. It is possible, however, 
that adipose tissue may respond to glucose, insulin and tri-
glycerides (and other associated stimuli not examined in 
this study, e.g. LPS) independent of each other, and adipose 
tissue sampling at different time points may have produced 
a different pattern of results. Although the exact stimuli 
would be difficult to isolate, understanding the dynamics of 
postprandial inflammatory responses in adipose tissue and 
how they relate to glucose control may ultimately provide 
insight regarding the aetiology of obesity-related insulin 
resistance.
Potential origin and roles of postprandial cytokine 
responses in adipose tissue
Cells within the adipose tissue stromavascular fraction, in 
particular macrophages, are likely to be the major sources 
of adipokines such as IL-6 and MCP-1 [30–32], although 
mature adipocytes may also make a substantive contribu-
tion [33]. Each component of the meal and the associated 
insulin response have been shown in vitro to affect inflam-
mation in both macrophages and adipocytes. For example, 
in experiments using (murine) 3T3-L1 adipocytes, insulin 
can dramatically enhance MCP-1 expression from these 
cells [34]. MCP-1 may be an important factor enhancing 
macrophage recruitment to adipose tissue (via repeated 
stimulation), as is observed in adipose tissue of obese indi-
viduals [35–38], and can also induce insulin resistance in 
adipocytes [34]. In vitro work has shown that IL-6 produc-
tion can be induced in macrophages by high levels of glu-
cose uptake via GLUT1 [39] and by fatty acids and lipopol-
ysaccharides produced by gram-negative bacteria present 
within the intestine following ingestion of triglycerides 
[40–42]. Although chronic elevation of IL-6 is typically 
regarded as detrimental to insulin resistance and cardio-
vascular health [43], acute oscillations in IL-6, as seen for 
example following exercise, may be important in maintain-
ing insulin sensitivity in muscle post-exercise [44, 45]. The 
implications of a postprandial increase in IL-6 gene expres-
sion within adipose tissue and its time course may therefore 
warrant further investigation.
Considerations and future work
Cytokine secretion from adipose tissue remained similar in 
samples taken before and 6 h after the meal, which could be 
interpreted as evidence that adipose tissue has ‘protective’ 
mechanisms to prevent acute increases in the secretion of 
these cytokines in response to changes in gene expression 
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(e.g. into the circulation). There appears to be large varia-
tion in postprandial secretion between participants, and this 
may reflect the wide ranges in adipose tissue responsive-
ness to the meal components and/or insulin and differences 
in relative proportions of adipocytes/non-adipocyte cells in 
adipose tissue. These results are limited to some extent by 
the small amount of tissue samples and data available for 
lean and overweight participants. Arterio-venous sampling 
may instead give a better indication of adipose tissue secre-
tion over the entire duration following the meal and any 
effects of adiposity.
Based on this study design, we cannot be absolutely cer-
tain that the meal directly caused the reported time-related 
changes. Ideally, we would have been able to include some 
kind of comparator trial in order to rule out other expla-
nations such as circadian rhythms. Such comparisons have 
been made previously in rats, which demonstrated that 
gene expression of inflammatory markers IL-6 and NF-KB 
was significantly increased (at 2 h) specifically following 
a high-fat meal compared with water [29]. However, even 
with such a study design it is difficult to conclude that the 
changes are due to feeding because of course extended fast-
ing per se also represents a physiological challenge. Fur-
thermore, it must be recognized that interpretation based on 
just two time points may not necessarily provide a full and 
valid reflection of the time course of events in vivo over the 
entire postprandial period. For example, there may have 
been insufficient time for synthesis of RNA transcripts/
proteins for secretion into the circulation by the 6-h time 
point, or some proteins may already have been released 
from storage vesicles. In this context, a number of changes 
in gene expression have been identified at 4 h following 
lipid challenges [4] and after only 3 h of hyperglycaemia 
[28] and 2 h of hyperinsulinaemia [26, 27]. Repeated adi-
pose biopsies to generate a time course would be useful but 
very challenging. It would also be interesting to investigate 
changes in adipose tissue following subsequent food intake, 
since blood glucose and insulin responses are known to be 
much lower after repeated feeding (i.e. Staub–Traugott 
effect) [46–48]. This could also help identify whether glu-
cose and insulin are indeed key drivers of the postprandial 
adipose tissue responses.
Conclusions
Although postprandial blood glucose and insulin responses 
are elevated with increasing adiposity, subcutaneous adi-
pose tissue from lean through to class I obese individu-
als shows similar postprandial inflammatory responses 
at the gene expression level. Postprandial inflammatory 
responses in adipose tissue therefore do not appear to be 
related to the greater postprandial metabolic response (i.e. 
hyperinsulinaemia) observed with increased adiposity. 
This may be part of a normal adipose tissue response to 
feeding, or a ‘normalized’ response due to either reduced 
responsiveness of adipose tissue to meal components (e.g. 
glucose/lipid) or insulin or similar net exposure per gram 
adipose tissue (i.e. after adjustment for differences in adi-
pose tissue mass).
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